☆ 4.6 Review

Novel insights into an old phenomenon: the no reflow

INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)

期刊

INTERNATIONAL JOURNAL OF CARDIOLOGY

卷 187, 期 -, 页码 273-280

出版社

ELSEVIER IRELAND LTD

DOI: 10.1016/j.ijcard.2015.03.359

关键词

No reflow; STEMI; Myocardial infarction; Microvascular obstruction; Cardiac magnetic resonance; Percutaneous coronary intervention

类别

Cardiac & Cardiovascular Systems

向作者/读者索取更多资源

Protocol

Reagent

摘要

Coronary artery diseases and particularly acute myocardial infarction are the leading causes of mortality and morbidity inwestern countries. Despite the achievements of the last decades with the advent of double antiplatelet therapy, new antithrombotics and reperfusion strategies (either pharmacological or mechanical), many patients still have adverse cardiovascular events after ST-segment elevation acute myocardial infarction; at least some of these adverse events are related to the no reflow phenomenon that occurs after primary percutaneous coronary intervention. In our review we will discuss the various aspects of this phenomenon. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Medicine, General & Internal

The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI

Luca Grancini, Davide Diana, Alice Centola, Giovanni Monizzi, Angelo Mastrangelo, Paolo Olivares, Piero Montorsi, Brunilda Alushi, Antonio L. Bartorelli, Alfredo R. Galassi

Summary: The SALINE technique using a thrombus aspiration catheter for super-selective intracoronary injection of saline solution was found to be a safe and effective strategy to reduce no-reflow in patients with STEMI. It improved flow restoration, ST-segment resolution, and led to better outcomes at 3-year follow-up compared to standard care of therapy.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Peripheral Vascular Disease

The ATRIA and Modified-ATRIA Scores in Evaluating the Risk of No-Reflow in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

Ozge Ozcan Abacioglu, Arafat Yildirim, Nermin Yildiz Koyunsever, Salih Kilic

Summary: The study found that ATRIA, especially the m-ATRIA-HS score, can be used to assess the risk of no-reflow in STEMI patients. In addition, age, higher CK-MB, neutrophil-to-lymphocyte ratio, and diabetes mellitus were also identified as other predictors for no-reflow.

ANGIOLOGY (2022)

添加到收藏夹

Review Medicine, General & Internal

Coronary No-Reflow after Primary Percutaneous Coronary Intervention-Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy

Gjin Ndrepepa, Adnan Kastrati

Summary: Coronary no-reflow (CNR) is a common occurrence in patients with ST-segment elevation myocardial infarction (STEMI) after reperfusion therapy. It is caused by microvascular obstruction (MVO) resulting from myocardial ischemia, distal embolization, and reperfusion-related injury. Currently, there is no therapy that consistently prevents or reverses CNR and provides clinical benefit in STEMI patients undergoing reperfusion.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Medicine, General & Internal

RDW as A Predictor for No-Reflow Phenomenon in DM Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Ying Sun, Jian Ren, Li Li, Chunsong Wang, Hengchen Yao

Summary: This study investigated the predictive value of red blood-cell distribution width (RDW) on no-reflow phenomenon (NRP) in ST-segment elevation myocardial infarction (STEMI) patients. The results showed that patients with high RDW had a higher likelihood of developing NRP. In patients with diabetes, RDW was found to be an independent predictor of NRP.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Effect of GP IIb/IIIa inhibitor duration on the clinical prognosis of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction with no-/slow-reflow phenomenon

Xiangming Hu, Weimian Wang, Jingguang Ye, Yan Lin, Bingyan Yu, Langping Zhou, Yingling Zhou, Haojian Dong

Summary: This study compared the efficacy and safety of short- and long-term GPI infusion in patients with STEMI and the no-/slow-reflow phenomenon, and found that prolonging the duration of GPI may not significantly improve the clinical outcome in real-world patients.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitors

Gjin Ndrepepa, Salvatore Cassese, Erion Xhepa, Michael Joner, Hendrik B. Sager, Sebastian Kufner, Karl-Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati

Summary: The frequency and prognostic value of coronary no-reflow (CNR) was investigated in studies that used stents and antithrombotic drugs in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI).

CLINICAL RESEARCH IN CARDIOLOGY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The Relationship Between TIMI Flow and MAPH Score in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI

Ferhat Siyamend Yurdam, Mehmet Kis

Summary: The aim of this study was to determine the relationship between the MAPH risk score and TIMI flow in patients with STEMI. The study found that the MAPH score and glycoprotein IIb/IIIa inhibitors were independent predictors of TIMI flow. A high MAPH score may indicate the presence of coronary no-reflow in patients with STEMI.

INTERNATIONAL HEART JOURNAL (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Sex-Related Differences in Thrombus Burden in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention

Maria Virginia Manzi, Sergio Buccheri, Sanjit S. Jolly, Felix Zijlstra, Ole Frobert, Bo Lagerqvist, Karim D. Mahmoud, Vladimir Dzavik, Emanuele Barbato, Giovanna Sarno, Stefan James

Summary: Women have a worse prognosis after ST-segment elevation myocardial infarction (STEMI), and this is related to thrombus burden (TB). Among patients with STEMI, high thrombus burden (HTB) is associated with 1-year cardiovascular death, recurrent myocardial infarction, heart failure, all-cause mortality, stroke, stent thrombosis, and target vessel revascularization. Female patients are more likely to experience stent thrombosis, cardiovascular death, and all-cause mortality than male patients in the presence of HTB.

JACC-CARDIOVASCULAR INTERVENTIONS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impact of Persistent Microvascular Obstruction Late After STEMI on Adverse LV Remodeling A CMR Study

Vicente Bodi, Jose Gavara, Maria P. Lopez-Lereu, Jose V. Monmeneu, Elena de Dios, Nerea Perez-Sole, Clara Bonanad, Victor Marcos-Garces, Joaquim Canoves, Gema Minana, Julio Nunez, David Moratal, Francisco J. Chorro, Jose F. Rodriguez-Palomares, Andrea Freixa, Roger Borras, Jose T. Ortiz-Perez, Cesar Rios-Navarro

Summary: This study used cardiac magnetic resonance (CMR) to investigate the impact of persistent microvascular obstruction (MVO) on adverse left ventricular remodeling (ALVR) after reperfused ST-segment elevation myocardial infarction (STEMI). The results showed that 6% of STEMI patients exhibited persistent MVO, which was associated with detrimental effects on left ventricular remodeling. Further research on microvascular injury repair is needed based on these findings.

JACC-CARDIOVASCULAR IMAGING (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Canada acute coronary syndrome risk score predicts no-/ slow-reflow in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

Enmin Xie, Qing Li, Zixiang Ye, Ziyu Guo, Yike Li, Nan Shen, Changan Yu, Yanxiang Gao, Jingang Zheng

Summary: The Canada Acute Coronary Syndrome (C-ACS) risk score was found to be able to predict the occurrence of no-/slow-reflow in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). In male patients, the C-ACS score showed an independent association with no-/slow-reflow and had predictive value for major adverse cardiovascular events.

HELIYON (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association between kaolin-induced maximum amplitude and slow-flow/ no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention

Qing Li, Enmin Xie, Yimin Tu, Yaxin Wu, Ziyu Guo, Peizhao Li, Yike Li, Xiaozhai Yu, Zixiang Ye, Changan Yu, Yanxiang Gao, Zheng Jingang

Summary: This study found that MAthrombin level is an independent risk factor for predicting slow-flow/no-reflow in STEMI patients undergoing primary PCI, with a nonlinear relationship between MAthrombin levels and slow-flow/no-reflow. Adverse clinical cardiovascular events in the long-term were also associated with slow-flow/no-reflow and MAthrombin levels.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Relationship between vitamin D and cholesterol levels in STEMI patients undergoing primary percutaneous coronary intervention

Monica Verdoia, Filippo Viglione, Annalisa Boggio, Daniele Stefani, Nicolo Panarotto, Aurelio Malabaila, Roberta Rolla, Pier Luigi Solda, Alessandro Stecco, Alessandro Carriero, Giuseppe De Luca

Summary: This study aimed to assess the impact of vitamin D on cholesterol levels among patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (pPCI). The results showed that lower levels of vitamin D were independently associated with a more atherogenic lipid profile.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Preprocedural Colchicine in Patients With Acute ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial (PodCAST-PCI)

Seyed Hossein Hosseini, Azita H. Talasaz, Mohammad Alidoosti, Masih Tajdini, Benjamin W. Van Tassell, Nasrin Etesamifard, Hessam Kakavand, Arash Jalali, Maryam Aghakouchakzadeh, Azin Gheymati, Mohammad Sadeghian, Yaser Jenab

Summary: This study aimed to investigate whether colchicine could prevent the occurrence of no-reflow phenomenon (NRP) and improve outcomes in patients with acute ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). The results showed that the use of colchicine before PPCI was not associated with a significant reduction in NRP rates and did not improve patient outcomes, including the occurrence of major adverse cardiac events (MACE) and left ventricular ejection fraction.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Elevated serum FGF21 levels predict heart failure during hospitalization of STEMI patients after emergency percutaneous coronary intervention

Lingyun Gu, Wenxi Jiang, Wenlong Jiang, Zhuowen Xu, Weizhang Li, Hua Zhang

Summary: This study found that elevated serum FGF21 levels were strongly associated with the occurrence of heart failure during hospitalization in patients with STEMI after emergency PCI. The results suggest that serum FGF21 levels may serve as a strong predictor for heart failure in STEMI patients undergoing emergency PCI.

PEERJ (2023)

添加到收藏夹

Article Medicine, General & Internal

Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention

Oreste Lanza, Nicola Cosentino, Claudia Lucci, Marta Resta, Mara Rubino, Valentina Milazzo, Monica De Metrio, Filippo Trombara, Jeness Campodonico, Jose Pablo Werba, Alice Bonomi, Giancarlo Marenzi

Summary: Prior statin therapy is associated with a better in-hospital clinical outcome in patients with STEMI undergoing primary PCI.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Trabecular complexity as an early marker of cardiac involvement in Fabry disease

Antonia Camporeale, Francesco Moroni, Davide Lazzeroni, Silvia Garibaldi, Maurizio Pieroni, Federico Pieruzzi, Paola Lusardi, Marco Spada, Renzo Mignani, Alessandro Burlina, Francesca Carubbi, Laura Econimo, Yuri Battaglia, Francesca Graziani, Silvia Pica, Kelvin Chow, Paolo G. Camici, Massimo Lombardi

Summary: This study used cardiac magnetic resonance imaging to analyze the complexity of myocardial trabeculae in Fabry cardiomyopathy. The results showed that the fractal dimensions of the trabeculae increased with the progression of the disease. The fractal dimensions were significantly correlated with T1 values, left ventricular mass, trabecular mass, and the Mainz Severity Score Index. This suggests that increased myocardial trabeculation is an early sign of cardiac involvement in Fabry cardiomyopathy.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2022)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Prevalence and outcome of patients with acute myocarditis and positive viral search on nasopharyngeal swab

Enrico Ammirati, Marisa Varrenti, Giacomo Veronese, Diana Fanti, Alice Nava, Manlio Cipriani, Patrizia Pedrotti, Andrea Garascia, Maurizio Bottiroli, Fabrizio Oliva, Manuela Bramerio, Silvio Veronese, Cristina Giannattasio, Emanuela Bonoldi, Carlo F. Perno, Paolo G. Camici, Maria Frigerio

EUROPEAN JOURNAL OF HEART FAILURE (2021)

添加到收藏夹

Correction Cardiac & Cardiovascular Systems

Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy (Feb, 10.1007/s12350-022-02911-y, 2022)

Raffaella Calabretta, Aurora Kokomani, Carlo Fumagalli, Iacopo Olivotto, Paolo G. Camici, Marcus Hacker, Roberto Sciagra

JOURNAL OF NUCLEAR CARDIOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy

Raffaella Calabretta, Aurora Kokomani, Carlo Fumagalli, Iacopo Olivotto, Paolo G. Camici, Marcus Hacker, Roberto Sciagra

Summary: This study analyzed the myocardial perfusion in AHCM patients and found that the microvascular impairment was more severe in the apical region, potentially associated with future aneurysmatic evolution.

JOURNAL OF NUCLEAR CARDIOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis

Enrico Ammirati, Laura Lupi, Matteo Palazzini, Nicholas S. Hendren, Justin L. Grodin, Carlo Cannistraci, Matthieu Schmidt, Guillaume Hekimian, Giovanni Peretto, Thomas Bochaton, Ahmad Hayek, Nicolas Piriou, Sergio Leonardi, Stefania Guida, Annalisa Turco, Simone Sala, Aitor Uribarri, Caroline M. Van de Heyning, Massimo Mapelli, Jeness Campodonico, Patrizia Pedrotti, Maria Isabel Barrionuevo Sanchez, Albert Ariza Sole, Marco Marini, Maria Vittoria Matassini, Mickael Vourc'h, Antonio Cannata, Daniel Bromage, Daniele Briguglia, Jorge Salamanca, Pablo Diez-Villanueva, Jukka Lehtonen, Florent Huang, Stephanie Russel, Francesco Soriano, Fabrizio Turrini, Manlio Cipriani, Manuela Bramerio, Mattia Di Pasquale, Aurelia Grosu, Michele Senni, Davide Farina, Piergiuseppe Agostoni, Stefania Rizzo, Monica De Gaspari, Francesca Marzo, Jason M. Duran, Eric D. Adler, Cristina Giannattasio, Cristina Basso, Theresa McDonagh, Mathieu Kerneis, Alain Combes, Paolo G. Camici, James A. de Lemos, Marco Metra

Summary: The prevalence of acute myocarditis (AM) in COVID-19 patients is estimated to be between 2.4 and 4.1 per 1000 hospitalized patients. Most cases of AM occur in the absence of pneumonia and are often complicated by hemodynamic instability.

CIRCULATION (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Perspectives in noninvasive imaging for chronic coronary syndromes

Doralisa Morrone, Francesco Gentile, Alberto Aimo, Matteo Cameli, Andrea Barison, Maria Elena Picoi, Marco Guglielmo, Angelo Villano, Antonio DeVita, Giulia Elena Mandoli, Maria Concetta Pastore, Francesco Barilla, Massimo Mancone, Roberto Pedrinelli, Ciro Indolfi, Pasquale Perrone Filardi, Saverio Muscoli, Isabella Tritto, Luca Bergamaschi, Carmine Pizzi, Paolo G. Camici, Mario Marzilli, Filippo Crea, Raffaele De Caterina, Gianluca Pontone, Danilo Neglia, Gaetano A. Lanza

Summary: The latest guidelines emphasize the importance of noninvasive imaging for selecting patients for further invasive angiography. In addition to coronary stenosis, other mechanisms such as vasospasm, microvascular disease, and energetic inefficiency have been shown to be important. Therefore, a pathophysiology-driven treatment approach has become a crucial objective, and multimodality imaging can provide deeper insights into the underlying mechanisms.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

添加到收藏夹

Article Hematology

RNA-seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy

Annalinda Pisano, Loredana Le Pera, Raffaella Carletti, Bruna Cerbelli, Maria G. Pignataro, Angelina Pernazza, Fabrizio Ferre, Maria Lombardi, Davide Lazzeroni, Iacopo Olivotto, Ornella E. Rimoldi, Chiara Foglieni, Paolo G. Camici, Giulia d'Amati

Summary: This study identified distinctive pathways between remodeled arterioles and cardiomyocytes in patients with HCM and controls at the transcriptome level. By analyzing the transcriptome profile, insights into the molecular pathways associated with microvessel remodeling in HCM can be obtained.

MICROCIRCULATION (2022)

添加到收藏夹

Meeting Abstract Cardiac & Cardiovascular Systems

PROGNOSTIC PERFORMANCE OF CARDIAC MAGNETIC RESONANCE IMAGING MARKERS VERSUS COMPLICATED CLINICAL PRESENTATION AFTER AN ACUTE MYOCARDITIS

Marisa Varrenti, Enrico Ammirati, Paola Sormani, Claudio Moro, Saverio D'elia, Paolo Bernasconi, Claudia Raineri, Giuseppina Quattrocchi, Angela Milazzo, Alberto Maestroni, Maria Grazia Valsecchi, Andrea Garascia, Fabrizio Oliva, Cristina Giannattasio, Paolo G. Camici, Patrizia Pedrotti

EUROPEAN HEART JOURNAL SUPPLEMENTS (2022)

添加到收藏夹

Meeting Abstract Cardiac & Cardiovascular Systems

PREVALENCE CHARACTERISTICS AND OUTCOMES OF COVID 19 ASSOCIATED ACUTE MYOCARDITIS

Matteo Palazzini, Laura Lupi, Enrico Ammirati, Cristina Giannattasio, Francesco Soriano, Patrizia Pedrotti, Daniele Briguglia, Massimo Mapelli, Jeness Campodonico, Piergiuseppe Agostoni, Sergio Leonardi, Annalisa Turco, Stefania Guida, Giovanni Peretto, Simone Sala, Paolo G. Camici, Francesca Marzo, Aurelia Grosu, Michele Senni, Fabrizio Turrini, Manuela Bramerio, Marco Marini, Maria Vittoria Matassini, Stefania Rizzo, Cristina Basso, Monica De Gaspari, Nicholas S. Hendren, Matthieu Schmidt, Thomas Bochaton, Nicolas Piriou, Aitor Ubarri, Caroline Van De Heyning, Albert Ariza Sole, Antonio Cannata, Jorge Salamanca, Jukka Lehtonen, Florent Huang, Eric D. Adler, Marco Metra

EUROPEAN HEART JOURNAL SUPPLEMENTS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiac magnetic resonance predictors of left ventricular remodelling following acute ST elevation myocardial infarction: The VavirimS study

Silvia Pica, Gabriele Crimi, Serenella Castelvecchio, Vittorio Pazzanese, Anna Palmisano, Massimo Lombardi, Lara Tondi, Antonio Esposito, Pietro Ameri, Claudia Canale, Alberto Cappelletti, Luca P. Alberti, Davide Tavano, Rita Camporotondo, Ilaria Costantino, Jenness Campodonico, Gianluca Pontone, Alessandra Villani, Gianluca Pio Gallone, Rocco A. Montone, Giampaolo Niccoli, Paola Gargiulo, Bruna Punzo, Marco Vicenzi, Stefano Carugo, Lorenzo Menicanti, Giuseppe Ambrosio, Paolo G. Camici

Summary: This study investigated the presence of left ventricular (LV) remodelling after ST-elevation myocardial infarction (STEMI) using cardiac magnetic resonance (CMR) imaging. The results showed that LV remodelling in the subacute phase may not be detrimental, but rather a compensatory response associated with improved LV ejection fraction (EF) at follow-up. However, LV remodelling accompanied by an increase in end-systolic volume index (LV-REMESV) was associated with a decrease in LV-EF, driven by the infarct size.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

添加到收藏夹

Review Medicine, General & Internal

Microvascular Dysfunction in Hypertrophic Cardiomyopathy

Francesco Pelliccia, Franco Cecchi, Iacopo Olivotto, Paolo G. Camici

Summary: Myocardial ischemia is a pathophysiological feature of hypertrophic cardiomyopathy that affects heart function and sudden cardiac death. Coronary microvascular dysfunction is the main factor contributing to myocardial ischemia, and thus a multimodality approach is necessary for the detailed assessment of microvascular dysfunction and ischemia.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prognostic association of plasma NT-proBNP levels in patients with microvascular angina-A report from the international cohort study by COVADIS

Akira Suda, Jun Takahashi, Maike Schwidder, Peter Ong, Daniel Ang, Colin Berry, Paolo G. Camici, Filippo Crea, Juan Carlos Kaski, Carl Pepine, Ornella Rimoldi, Udo Sechtem, Satoshi Yasuda, John F. Beltrame, C. Noel Bairey Merz, Hiroaki Shimokawa

Summary: This study found that plasma levels of NT-proBNP may serve as a novel prognostic biomarker for patients with microvascular angina (MVA), as it is significantly associated with the incidence of major adverse cardiovascular events (MACE).

IJC HEART & VASCULATURE (2022)

添加到收藏夹

Article Medicine, General & Internal

Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment

Antonella Scala, Andrea Erriquez, Filippo Maria Verardi, Andrea Marrone, Ennio Scollo, Michele Trichilo, Alessandro Durante, Delio Tedeschi, Bernardo Cortese, Alfonso Ielasi, Giuliano Valentini, Matteo Tebaldi, Gianluca Campo, Rita Pavasini, Simone Biscaglia

Summary: This study investigates the prognostic value of Syntax Score II 2020 in patients with left main or multivessel disease, and its ability to predict treatment outcomes. The findings suggest that integrating Syntax Score II 2020 with FFR evaluation can improve risk prediction and therapeutic guidance.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Meeting Abstract Cardiac & Cardiovascular Systems

Acute myocarditis associated with desmosomal gene variants

E. Ammirati, F. Raimondi, N. Piriou, S. A. Mohiddin, M. Imazio, G. Aquaro, I. Olivotto, C. M. Van De Heyning, G. Peretto, M. Merlo, S. Klaassen, W. Poller, E. D. Adler, P. G. Camici, L. T. Cooper

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Meeting Abstract Cardiac & Cardiovascular Systems

The Impact of Living with INOCA

M. Gulati, N. Khan, M. George, C. Berry, A. Chieffo, P. G. Camici, F. Crea, J. -C. Kaski, M. Marzilli, C. N. B. Merz

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.